Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON55835Active, not recruiting
Open-label trial in Infection, sponsored by Erasmus MC. Primary endpoints: Length of ICU stay and Delta pharmacodynamic target attainment. Started Oct 2018; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON55835.